CAF reprogramming inhibits ovarian cancer progression

被引：23
|
作者：
Yeung, Tsz-Lun [1 ]
Leung, Cecilia S. [1 ,2 ]
Mok, Samuel C. [1 ,2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[2] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA
来源：
CELL CYCLE | 2014年 / 13卷 / 24期
关键词：
SURVIVAL;
D O I：
10.4161/15384101.2014.988106
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：3783 / 3784
页数：2
相关论文
共 50 条
  • [1] Reprogramming the TGF-beta signaling in cancer-associated fibroblasts inhibits ovarian cancer progression
    Yeung, Tsz-Lun
    Leung, Cecilia S.
    Wong, Kwong-Kwok
    Mok, Samuel C.
    [J]. CANCER RESEARCH, 2015, 75
  • [2] Geranylgeranylacetone inhibits ovarian cancer progression in vitro and in vivo
    Hashimoto, Kae
    Morishige, Ken-ichirou
    Sawada, Kenjiro
    Ogata, Seiji
    Tahara, Masahiro
    Shimizu, Shoko
    Sakata, Masahiro
    Tasaka, Keiichi
    Kimura, Tadashi
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 356 (01) : 72 - 77
  • [3] PBOV1 correlates with progression of ovarian cancer and inhibits proliferation of ovarian cancer cells
    Wang, Lan
    Niu, Chun-Hao
    Wu, Shu
    Wu, Hong-Mei
    Ouyang, Fei
    He, Mian
    He, Shan-Yang
    [J]. ONCOLOGY REPORTS, 2016, 35 (01) : 488 - 496
  • [4] Metabolic reprogramming in ovarian cancer
    Ha, Ji Hee
    Radhakrishnan, Rangasudhagar
    Ward, Jeremy D.
    Jayaraman, Muralidharan
    Dhanasekaran, Danny N.
    [J]. CANCER RESEARCH, 2016, 76
  • [5] Metabolic reprogramming and cancer progression
    Faubert, Brandon
    Solmonson, Ashley
    DeBerardinis, Ralph J.
    [J]. SCIENCE, 2020, 368 (6487) : 152 - +
  • [6] Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
    Georgoudaki, Anna-Maria
    Prokopec, Kajsa E.
    Boura, Vanessa F.
    Hellqvist, Eva
    Sohn, Silke
    Ostling, Jeanette
    Dahan, Rony
    Harris, Robert A.
    Rantalainen, Mattias
    Klevebring, Daniel
    Sund, Malin
    Brage, Suzanne Egyhazi
    Fuxe, Jonas
    Rolny, Charlotte
    Li, Fubin
    Ravetch, Jeffrey V.
    Karlsson, Mikael C. I.
    [J]. CELL REPORTS, 2016, 15 (09): : 2000 - 2011
  • [7] Knockdown of ALPK2 inhibits the development and progression of Ovarian Cancer
    Xiaogang Zhu
    Siqi Yan
    Songshu Xiao
    Min Xue
    [J]. Cancer Cell International, 20
  • [8] Isorhamnetin inhibits progression of ovarian cancer by targeting ESR1
    Wang, Manman
    Xu, Zhengtan
    Cai, Qi
    Deng, Yanmei
    Shi, Weiqiao
    Zhou, Hongyu
    Wang, Dajiang
    Li, Jian
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2022,
  • [9] Knockdown of ALPK2 inhibits the development and progression of Ovarian Cancer
    Zhu, Xiaogang
    Yan, Siqi
    Xiao, Songshu
    Xue, Min
    [J]. CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [10] Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
    Shi, Gang
    Shi, Pengyi
    Yu, Yan
    Xu, Jia
    Ma, Jinhu
    Zhang, Yong
    Dong, Zhexu
    Shen, Lanlin
    Dai, Lei
    Cheng, Lin
    Cheng, Ping
    Deng, Hongxin
    [J]. MOLECULAR THERAPY-ONCOLYTICS, 2021, 23 : 488 - 500
12345